ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,095Medicare Part D Prescriptions Filled, Including Refills

Rank: 511 out of 5176

$390K Total Retail Price of All Prescriptions

Rank: 1717 out of 5176

209 Patients Receiving at Least One Drug in Part D
98%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

33% of this provider’s 209 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 10,668 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

53 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
OMEPRAZOLE 566 544 1 3
POLYETHYLENE GLYCOL 3350 489 433 2 74
FUROSEMIDE 453 453 3 8
LEVOTHYROXINE SODIUM 399 399 4 4
METOPROLOL TARTRATE 391 382 5 6
JANTOVEN 358 320 6 106
LISINOPRIL 336 336 7 5
QUETIAPINE FUMARATE 282 271 8 75
CITALOPRAM HBR 278 278 9 31
DONEPEZIL HCL 276 276 10 28
OXYCODONE HCL 264 262 S2 11 121
SIMVASTATIN 193 193 12 1
NAMENDA 180 166 13 47
SERTRALINE HCL 179 165 14 30
TRAZODONE HCL 176 162 15 71
GABAPENTIN 160 160 16 21
AMLODIPINE BESYLATE 157 156 17 2
KLOR-CON M20 146 146 18 129
LIDODERM 145 145 19 59
VITAMIN D2 140 136 20 214
RISPERIDONE 126 126 21 78
ATORVASTATIN CALCIUM 123 109 22 9
SEROQUEL 104 101 23 166
CYMBALTA 103 103 24 90
DIVALPROEX SODIUM 92 78 25 104
LEVETIRACETAM 92 77 25 92
IPRATROPIUM-ALBUTEROL 90 90 27 138
DIGOXIN 88 88 28 56
ALENDRONATE SODIUM 88 74 28 18
ATENOLOL 86 86 30 12
PAROXETINE HCL 85 85 31 93
OXYCONTIN 83 75 S2 32 294
METOPROLOL SUCCINATE 81 81 33 11
DILTIAZEM 24HR ER 78 78 34 136
ESCITALOPRAM OXALATE 78 78 34 89
MIRTAZAPINE 75 75 36 45
HYDROCHLOROTHIAZIDE 72 71 37 10
CARBIDOPA-LEVODOPA 71 71 38 98
TAMSULOSIN HCL 71 59 38 20
FLUOXETINE HCL 65 50 40 132
PREDNISONE 65 65 40 52
ALBUTEROL SULFATE 64 64 42 99
LOSARTAN POTASSIUM 63 63 43 14
SANTYL 59 59 44 124
AMOXICILLIN 59 59 44 163
NOVOLIN N 56 56 46 304
LATANOPROST 55 55 47 185
VOLTAREN 54 54 48 97
OXYBUTYNIN CHLORIDE ER 53 53 49 204
DILTIAZEM HCL 53 53 49 316
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 3, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.